TAIHO ONCOLOGY

WIPO WIPO 2014

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark TAIHO ONCOLOGY was filed as Figurative mark on 03/25/2014 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Letters presenting a special form of writing #Colours #Red, pink, orange

Trademark Details Last update: October 14, 2022

Trademark form Figurative mark
File reference 1220422
Register number 5654402
Countries China European Community South Korea Singapore United States of America (USA) Vietnam
Base trademark JP No. 5654402, March 7, 2014
Application date March 25, 2014
Expiration date March 25, 2024

Trademark owner

1-27 Kandanishiki-cho,
Chiyoda-ku
JP

Trademark representatives

c/o Saegusa & Partners, Tokyo Office, TORANOMON MITSUI Building 9F, JP

goods and services

05 Anti-cancer preparations and substances; anti-ulcerogenic preparations and substances; pharmaceutical preparations and substances for the treatment of immunological diseases; pharmaceutical preparations and substances for the treatment of urinary diseases; therapeutic preparations and substances for pain; antiemetic preparations and substances; diagnostic preparations and substances; drugs for genetic testing; pharmaceutical preparations; dietary supplements for humans; dietetic foods adapted for medical purposes
44 Diagnostic services of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing information relating to the treatment or prevention of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; consultation services relating to the treatment and diagnosis of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical counseling services relating to the treatment of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical analysis services and genetic testing for the diagnosis and prognosis of the expected progression of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to efficacy, side effects, interactions of pharmaceuticals and medication; collecting and managing clinical data in relation to clinical trials of pharmaceuticals; medical services; providing medical information; physical examination; dentistry; preparation and dispensing of medications

Trademark history

Date Document number Area Entry
October 4, 2022 2022/41 Gaz US RAW: Total Invalidation
June 27, 2019 2019/28 Gaz CN RAW: Rule 18ter(4) all goods and services protected
April 11, 2018 2018/38 Gaz VN RAW: Rule 18ter(2)(i) GP following a provisional refusal
November 13, 2015 2015/49 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
November 5, 2015 2015/45 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 26, 2015 2015/45 Gaz VN Rejection
October 23, 2015 2015/44 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 13, 2015 2015/43 Gaz CN Rejection
August 25, 2015 2015/35 Gaz EM Rejection
March 16, 2015 2015/12 Gaz KR Rejection
March 4, 2015 2015/12 Gaz SG Rejection
November 13, 2014 2014/46 Gaz US Rejection
March 25, 2014 2014/41 Gaz JP Registration

ID: 141220422